Cost · Not a partner
One month, no commitment
$273.99/mo, month to month
No commitment, and no cheaper rung: this is what the site publishes.
| Plan | Per month | Charged today |
|---|---|---|
1 Month Continued CareSource$273.99 (incl. $199 medication + $74.99 membership)https://www.ivimhealth.com/compounded-semaglutide-cc1m-googleshop/ — read 2026-09-02 | $273.99 | $273.99 |
2 Month JumpstartSource$349.98 (incl. $200 medication + $149.98 membership)https://www.ivimhealth.com/compounded-semaglutide-js2m-googleshop/ — read 2026-09-02 | $174.99 | $349.98 |
2 Months Continued CareSource$528.98 (incl. $379 medication + $149.98 membership)https://www.ivimhealth.com/compounded-semaglutide-cc2m-googleshop/ — read 2026-09-02 | $264.49 | $528.98 |
4 Month JumpstartSource$599.96 (incl. $300 medication + $299.96 membership)https://www.ivimhealth.com/compounded-semaglutide-js4m-googleshop/ — read 2026-09-02 | $149.99 | $599.96 |
4 Months Continued CareSource$798.96 (incl. $499 medication + $299.96 membership)https://www.ivimhealth.com/compounded-semaglutide-cc4m-googleshop/ — read 2026-09-02 | $199.74 | $798.96 |
6 Month JumpstartSource$899.94 (incl. $450 medication + $449.94 membership)https://www.ivimhealth.com/compounded-semaglutide-js6m-googleshop/ — read 2026-09-02 | $149.99 | $899.94 |
Every figure above is Ivím's own total, with its own split printed beside it — the shop pages state the price as, for example, “$899.94 (incl. $450 medication + $449.94 membership)”, so not one figure here had to be worked out. Microdosing is a third program priced identically to Jumpstart at every term: 2 months $349.98, 4 months $599.96, 6 months $899.94. The $75 and $133 on the microdosing page are the medication halves of the six-month rungs, before the $74.99 a month membership.
| Plan | Per month | Charged today |
|---|---|---|
1 Month Continued CareSource$374.99 (incl. $300 medication + $74.99 membership)https://www.ivimhealth.com/compounded-tirzepatide-cc1m-googleshop/ — read 2026-09-02 | $374.99 | $374.99 |
2 Month JumpstartSource$549.98 (incl. $400 medication + $149.98 membership)https://www.ivimhealth.com/compounded-tirzepatide-js2m-googleshop/ — read 2026-09-02 | $274.99 | $549.98 |
2 Months Continued CareSource$699.98 (incl. $550 medication + $149.98 membership)https://www.ivimhealth.com/compounded-tirzepatide-cc2m-googleshop/ — read 2026-09-02 | $349.99 | $699.98 |
4 Month JumpstartSource$895.96 (incl. $596 medication + $299.96 membership)https://www.ivimhealth.com/compounded-tirzepatide-js4m-googleshop/ — read 2026-09-02 | $223.99 | $895.96 |
4 Months Continued CareSource$1,199.96 (incl. $900 medication + $299.96 membership)https://www.ivimhealth.com/compounded-tirzepatide-cc4m-googleshop/ — read 2026-09-02 | $299.99 | $1,199.96 |
6 Month JumpstartSource$1,247.94 (incl. $798 medication + $449.94 membership)https://www.ivimhealth.com/compounded-tirzepatide-js6m-googleshop/ — read 2026-09-02 | $207.99 | $1,247.94 |
Tirzepatide's six-month Continued Care and six-month Jumpstart are the same price, $1,247.94, and Microdosing matches Jumpstart at every term: 2 months $549.98, 4 months $895.96, 6 months $1,247.94. The per-month figures in this table are the stated total divided by the stated term; where that does not come out to the cent — $1,247.94 over six months — the column rounds and the total is the figure to trust.
$273.99 buys one month of compounded semaglutide, $374.99 one month of tirzepatide. Ivím states both as totals with the arithmetic beside them: “$273.99 (incl. $199 medication + $74.99 membership)”.
Only one program sells a single month, and it is the one called Continued Care. Ivím's own answer on how the programs work is “Our GLP-1 ID programs are structured based on the duration you select at checkout. Most patients begin with the Jumpstart option, which is a 4-month commitment.” Jumpstart starts at two months, $349.98 charged today.
The number on the pricing page is $75. It is the medication half of the six-month rung, and the whole rung is “$899.94 (incl. $450 medication + $449.94 membership)”. The microdosing table prints the same thing more honestly than the program page does: a grid of $75, $100, $133, $149 and $200 with the line “+ $74.99 /mo Program fee” under it. On the GLP-1 ID page that footnote is gone and “starting at* $75/mo” carries no term at all.
Buying longer does not always cost less per month, and tirzepatide is where it shows. Four months of Jumpstart is $895.96 and four months of Continued Care is $1,199.96 — the same drug, the same length, $304 apart. At six months the two programs converge on $1,247.94.
Two FDA-approved pills sit outside all of that, at prices Ivím says it does not set. The Wegovy Pill runs $149 a month at the starting dose and steps to $199 and then $299 — “Pricing set by Novo Nordisk. Ivím membership ($75/mo) required for clinical support and is billed separately.” Foundayo, which Ivím describes as “Foundayo™ (orforglipron) is an FDA-approved oral weight loss medication from Eli Lilly”, runs the same $149 / $199 / $299 shape under the heading “Manufacturer-set pricing through Eli Lilly.” Neither is on the ladder above, because the ladder is what Ivím charges.
Leaving early has a price of its own, in the terms: “an administrative/restocking fee of $100 for each undeveloped three-month portion of your plan or $50 for each undeveloped two-month portion”.
The rest of the review — what the service is like and who should skip it — is on the Ivím Health review. Prices move; this page was read September 2026, and the company's own site is the current source.
To see every plan above priced out line by line — the rate, any required membership, any published consultation fee, and what a prepay term charges today — use the real cost calculator. It reads the same ladder this page does, so the two cannot disagree.
How Ivím Health's advertised figure compares with every other company's, in each company's own words and sorted by the size of the gap, is on the September 2026 Price Gap Index.
Ivím Health is not a partner. We link to them from the review and earn nothing from it.
More reviews on the index; the rules behind them are on how we review.